Literature DB >> 3321362

Infections caused by Mycobacterium szulgai in humans.

J M Maloney1, C R Gregg, D S Stephens, F A Manian, D Rimland.   

Abstract

Mycobacterium szulgai is a scotochromogenic species that has recently been recognized as a human pathogen. Twenty-four cases of disease caused by M. szulgai in humans have been reported in the English-language literature. The clinical features of these cases were reviewed, and three additional cases (two pulmonary, one extrapulmonary) were studied. Pulmonary disease indistinguishable from that caused by Mycobacterium tuberculosis was the commonest type of infection caused by M. szulgai (18 of 27 cases). Olecranon bursitis was reported in three cases, and disseminated infection was noted in three cases occurring in immunocompromised patients. M. szulgai is more susceptible to standard antimycobacterial agents than are other nontuberculous mycobacteria, notably the Mycobacterium avium complex. Clinical improvement and cure of pulmonary disease can be anticipated when treatment includes at least three drugs effective in in vitro susceptibility tests. Surgical excision appears unnecessary in pulmonary disease but may be indicated in olecranon bursitis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3321362     DOI: 10.1093/clinids/9.6.1120

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  12 in total

Review 1.  Mycobacterium szulgai: an unusual cause of disseminated mycobacterial infections.

Authors:  S Riedel; K Dionne; C Ellis; A Duffield; K C Carroll; N M Parrish
Journal:  Infection       Date:  2011-10-29       Impact factor: 3.553

Review 2.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Beware the steroid responsive nature of a pyrexial illness.

Authors:  S C Richards; S K Mukherjee; N D Hopkinson
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

5.  Infection by Mycobacterium szulgai in a patient with pulmonary tuberculosis.

Authors:  J M Olmos; F G Peralta; A Mellado; J González-Macías
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

6.  Pseudoepidemic due to a unique strain of Mycobacterium szulgai: genotypic, phenotypic, and epidemiological analysis.

Authors:  Qing Zhang; Randa Kennon; Maureen A Koza; Kristina Hulten; Jill E Clarridge
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 7.  Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.

Authors:  S E Hoffner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

8.  Clinical significance of Mycobacterium asiaticum isolates in Queensland, Australia.

Authors:  Miriam Grech; Robyn Carter; Rachel Thomson
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

9.  First pulmonary case reported in Argentina of infection with mycobacterium szulgai, a rare pathogen.

Authors:  M Gutierrez; M Feola; L Lenge; R Rey; M Hoffman
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

10.  Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system.

Authors:  B A Brown; R J Wallace; G O Onyi
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.